Pegfilgrastim ANF

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePegfilgrastim ANF
Drug Alias NameANF-RhoPEG-G-CSF-ANF
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesProlong Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA13
Related LinksN/A